All updated as on -
The market for legionella testing was estimated to be worth USD 226.29 million in 2022 and is anticipated to grow to USD 455.99 million by 2030, with a predicted CAGR of 10.1%.
Due to the increased incidence of legionnaire's infection, Pontiac fever, and pneumonia, the global market is anticipated to expand at a significant rate. The COVID-19 respiratory pandemic, rising sanitization awareness, and a growing focus on infectious disease prevention are further factors that are likely to increase demand for Legionella testing kits. A bacterium species known as legionella thrives mostly in freshwater environments including showers, bathtubs, ponds, and swimming pools. Since the U.S. had a pandemic of Legionella infections in 1997, strict standards have been established for routine monitoring of freshwater sources. Popular commercially accessible diagnostics include the urine antigen test, the microbial culture method, and the more recently introduced sophisticated PCR technology.
Most nations throughout the world are in a state of lockdown as a result of the COVID-19 outbreak. Since many commercial building storage systems have water in them that isn't used for several days, Legionella species can flourish there. The governments of numerous nations have advised mandatory testing of these water sources prior to beginning operations at these locations in order to stop the Legionella outbreak. To check for the lack of Legionella species growth, Wirehouse, a U.K.-based provider of employment law and health and safety services, suggests a Legionella testing service visit at the workplace.
Due to their weakened immune systems, elderly persons are more susceptible to infections, which makes this factor crucial to the global market for legionella testing. The deadly form of pneumonia known as legionnaires' disease is brought on by a particular type of bacterium called legionella. checks in urine, sputum, or blood for certain microorganisms. A legionellosis infection occurs in people who breathe in a mist or minute drops of water harboring the bacteria. The bacteria cannot be passed from one person to another. However, if a lot of individuals are exposed to the same contaminated water supply, a disease outbreak could occur. As a result, some people do not get sick. If you are older than fifty, have a chronic illness like diabetes or renal failure, smoke, have a weakened immune system from cancer or HIV/AIDS, or take immune-suppressing drugs, you have a higher risk of getting an infection.
The European Centre for Disease Prevention and Control (ECDC) (May 2022) states that Legionnaires' disease is still a rare and sporadic respiratory infection, with an overall notification rate for the EU/EEA in 2020 of 1.9 cases per 100,000 people. 72% of all registered cases came from France, Germany, Italy, and Spain. Additionally, the US CDC reports that from 1992 to 2002, the age-standardized average incidence was 0.48 instances per 100,000 people, compared to 2.71/100,000 in 2018.
Inadequate reimbursements are the main barrier to the market's expansion. Over the past 40 years, medical testing has suffered a 40% decrease in reimbursement, according to MedPAC (Medicare Payment Advisory Commission). The use of novel diagnostic procedures in clinical laboratories will be significantly hampered by this drop and extra budgetary worries among healthcare organizations.
In order to combat pandemics of infectious diseases that are spreading quickly, the technology behind molecular diagnostics are improving quickly. It takes a lot of time and effort to perform the traditional Legionella testing procedure, which uses microbial culture technology. However, because to its capacity to identify Legionella species serogroups, it was the test method most frequently used before to the development of the PCR test. PCR is quick, has a sensitivity range of 95-99%, and can quickly identify all serotypes of the Legionella species. Real-time PCR kits are being released at a faster rate, and their geographic coverage has increased, which has led to a greater uptake of this test method globally.
Report Coverage
Global Legionella Testing research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Legionella Testing report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Legionella Testing competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Legionella Testing market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Legionella Testing market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Legionella Testing market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Quidel Corporation (U.S.), Beckman Coulter Inc., Alere, Inc., Roche Diagnostics, Dickinson and Company (BD), Abbott (Alere) (U.S.), Merck KGaA, Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), BD (U.S.), bioMérieux (France), IDEXX Corporation (U.S.), Eurofins Scieentific (Luxembourg), Others
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Legionella Testing market based on the below-mentioned segments:
Global Legionella Testing Market, By Type
Culture Methods
Urinary Antigen Tests
Direct Fluorescent Antibody Tests
PCR
Global Legionella Testing market, By Application
Water Testing
IVD Testing
Other Applications
Global Legionella Testing Market, By End User
Hospitals
Diagnostic Laboratories
Water & Other Industries
Other End Users
Global Legionella Testing market, Regional Analysis
Due to the increased incidence of legionnaire's infection, Pontiac fever, and pneumonia, the global market is anticipated to expand at a significant rate. The COVID-19 respiratory pandemic, rising sanitization awareness, and a growing focus on infectious disease prevention are further factors that are likely to increase demand for Legionella testing kits. A bacterium species known as legionella thrives mostly in freshwater environments including showers, bathtubs, ponds, and swimming pools. Since the U.S. had a pandemic of Legionella infections in 1997, strict standards have been established for routine monitoring of freshwater sources. Popular commercially accessible diagnostics include the urine antigen test, the microbial culture method, and the more recently introduced sophisticated PCR technology.
Most nations throughout the world are in a state of lockdown as a result of the COVID-19 outbreak. Since many commercial building storage systems have water in them that isn't used for several days, Legionella species can flourish there. The governments of numerous nations have advised mandatory testing of these water sources prior to beginning operations at these locations in order to stop the Legionella outbreak. To check for the lack of Legionella species growth, Wirehouse, a U.K.-based provider of employment law and health and safety services, suggests a Legionella testing service visit at the workplace.
Due to their weakened immune systems, elderly persons are more susceptible to infections, which makes this factor crucial to the global market for legionella testing. The deadly form of pneumonia known as legionnaires' disease is brought on by a particular type of bacterium called legionella. checks in urine, sputum, or blood for certain microorganisms. A legionellosis infection occurs in people who breathe in a mist or minute drops of water harboring the bacteria. The bacteria cannot be passed from one person to another. However, if a lot of individuals are exposed to the same contaminated water supply, a disease outbreak could occur. As a result, some people do not get sick. If you are older than fifty, have a chronic illness like diabetes or renal failure, smoke, have a weakened immune system from cancer or HIV/AIDS, or take immune-suppressing drugs, you have a higher risk of getting an infection.
The European Centre for Disease Prevention and Control (ECDC) (May 2022) states that Legionnaires' disease is still a rare and sporadic respiratory infection, with an overall notification rate for the EU/EEA in 2020 of 1.9 cases per 100,000 people. 72% of all registered cases came from France, Germany, Italy, and Spain. Additionally, the US CDC reports that from 1992 to 2002, the age-standardized average incidence was 0.48 instances per 100,000 people, compared to 2.71/100,000 in 2018.
Inadequate reimbursements are the main barrier to the market's expansion. Over the past 40 years, medical testing has suffered a 40% decrease in reimbursement, according to MedPAC (Medicare Payment Advisory Commission). The use of novel diagnostic procedures in clinical laboratories will be significantly hampered by this drop and extra budgetary worries among healthcare organizations.
In order to combat pandemics of infectious diseases that are spreading quickly, the technology behind molecular diagnostics are improving quickly. It takes a lot of time and effort to perform the traditional Legionella testing procedure, which uses microbial culture technology. However, because to its capacity to identify Legionella species serogroups, it was the test method most frequently used before to the development of the PCR test. PCR is quick, has a sensitivity range of 95-99%, and can quickly identify all serotypes of the Legionella species. Real-time PCR kits are being released at a faster rate, and their geographic coverage has increased, which has led to a greater uptake of this test method globally.
Report Coverage
Global Legionella Testing research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Legionella Testing report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Legionella Testing competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Legionella Testing market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2030 |
| Base Year | 2022 |
| Forecast Period | 2022-2030 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Quidel Corporation (U.S.), Beckman Coulter Inc., Alere, Inc., Roche Diagnostics, Dickinson and Company (BD), Abbott (Alere) (U.S.), Merck KGaA, Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), BD (U.S.), bioMérieux (France), IDEXX Corporation (U.S.), Eurofins Scieentific (Luxembourg), Others |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Legionella Testing Market from 2021 to 2030.
- Market Forecast for Legionella Testing Market from 2021 to 2030.
- Regional Market Share and Revenue from 2021 to 2030.
- Country Market share within region from 2021 to 2030.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Legionella Testing competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Legionella Testing
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Legionella Testing market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Legionella Testing market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Quidel Corporation (U.S.), Beckman Coulter Inc., Alere, Inc., Roche Diagnostics, Dickinson and Company (BD), Abbott (Alere) (U.S.), Merck KGaA, Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), BD (U.S.), bioMérieux (France), IDEXX Corporation (U.S.), Eurofins Scieentific (Luxembourg), Others
Primary Target Market
- Market Players of Legionella Testing
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Legionella Testing market based on the below-mentioned segments:
Global Legionella Testing Market, By Type
Culture Methods
Urinary Antigen Tests
Direct Fluorescent Antibody Tests
PCR
Global Legionella Testing market, By Application
Water Testing
IVD Testing
Other Applications
Global Legionella Testing Market, By End User
Hospitals
Diagnostic Laboratories
Water & Other Industries
Other End Users
Global Legionella Testing market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive legionella testing market market research and competitor analysis for your business to help you develop more profound insights into the legionella testing market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the legionella testing market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.